Details:
The agreement, which anchors a previous MOU entered by the companies, includes exclusivity for Panaxia products, as well as an option for scaling the distribution to additional countries, also including further major European countries.
Lead Product(s): Cannabis products
Therapeutic Area: Trauma (Emergency, Injury, Surgery) Product Name: Undisclosed
Highest Development Status: Undisclosed Product Type: Undisclosed
Partner/Sponsor/Collaborator: Panaxia
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement July 22, 2020